This inventor holds 3 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1983-1987.
Location History:
- Basel, CH (1983 - 1987)
- Basle, CH (1987)
Company Filing History:
Years Active: 1983-1987
Title: Max P Seiler: Innovator in Pharmaceutical Development
Introduction
Max P Seiler is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that serve various medical purposes. With a total of 3 patents, his work has garnered attention in the scientific community.
Latest Patents
Among his latest patents, Seiler has developed a pharmaceutical active compound known as 1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinoline. This compound, which features a 6- or 8-monooxy- or 6,8-dioxy- structure, is particularly useful as a prolactin secretion inhibitor, dopaminergic agent, and dopamine receptor stimulating agent. Additionally, he has worked on indolophenanthridines, specifically 4,6,6a,7,8,12b-hexahydro-indolo[4,3-ab]phenanthridines, which are recognized for their potential as dopaminergic and analgesic agents.
Career Highlights
Max P Seiler is currently employed at Sandoz GmbH, a prominent company in the pharmaceutical industry. His work at Sandoz has allowed him to focus on the development of innovative therapeutic agents that address critical health issues.
Collaborations
Throughout his career, Seiler has collaborated with esteemed colleagues, including Alexander Hagenbach and Hans J Wuthrich. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Max P Seiler's contributions to pharmaceutical innovation highlight his expertise and dedication to improving medical treatments. His patents reflect a commitment to advancing healthcare through scientific research and development.